Literature DB >> 24677493

Autosomal dominant brachyolmia in a large Swedish family: phenotypic spectrum and natural course.

Giedre Grigelioniene1, Stefan Geiberger, Eva Horemuzova, Eva Moström, Nina Jäntti, Lo Neumeyer, Eva Åström, Magnus Nordenskjöld, Ann Nordgren, Outi Mäkitie.   

Abstract

Autosomal dominant brachyolmia (Type 3, OMIM #113500) belongs to a group of skeletal dysplasias caused by mutations in the transient receptor potential cation channel, subfamily V, member 4 (TRPV4) gene, encoding a Ca++-permeable, non-selective cation channel. The disorder is characterized by disproportionate short stature with short trunk, scoliosis and platyspondyly. The phenotypic variability and long-term natural course remain inadequately characterized. The purpose of this study was to describe a large Swedish family with brachyolmia type 3 due to a heterozygous TRPV4 mutation c.1847G>A (p.R616Q) in 11 individuals. The mutation has previously been detected in another family with autosomal dominant brachyolmia [Rock et al., 2008]. Review of hospital records and patient assessments indicated that clinical symptoms of brachyolmia became evident by school age with chronic pain in the spine and hips; radiographic changes were evident earlier. Growth was not affected during early childhood but deteriorated with age in some patients due to increasing spinal involvement. Affected individuals had a wide range of subjective symptoms with chronic pain in the extremities and the spine, and paresthesias. Our findings indicate that autosomal dominant brachyolmia may be associated with significant long-term morbidity, as seen in this family.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  TRPV4; autosomal dominant brachyolmia; brachydactyly; brachyolmia type 3; chronic pain; overfaced pedicles; paresthesias; platyspondyly; scoliosis; short spine

Mesh:

Substances:

Year:  2014        PMID: 24677493     DOI: 10.1002/ajmg.a.36502

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  5 in total

1.  Autosomal dominant brachyolmia: transient metaphyseal striations.

Authors:  Yun-Jung Lim; Hye-Ran Lee; Ok-Hwa Kim; Tae-Joon Cho; Kun-Bo Park
Journal:  Skeletal Radiol       Date:  2017-06-10       Impact factor: 2.199

2.  Autosomal recessive brachyolmia: early radiological findings.

Authors:  Atsuhiko Handa; Emma Tham; Zheng Wang; Eva Horemuzova; Giedre Grigelioniene
Journal:  Skeletal Radiol       Date:  2016-08-21       Impact factor: 2.199

3.  The newest TRP channelopathy: Gain of function TRPM3 mutations cause epilepsy and intellectual disability.

Authors:  Siyuan Zhao; Tibor Rohacs
Journal:  Channels (Austin)       Date:  2021-12       Impact factor: 3.493

4.  Mutations in the latent TGF-beta binding protein 3 (LTBP3) gene cause brachyolmia with amelogenesis imperfecta.

Authors:  Mathilde Huckert; Corinne Stoetzel; Supawich Morkmued; Virginie Laugel-Haushalter; Véronique Geoffroy; Jean Muller; François Clauss; Megana K Prasad; Frédéric Obry; Jean Louis Raymond; Marzena Switala; Yves Alembik; Sylvie Soskin; Eric Mathieu; Joseph Hemmerlé; Jean-Luc Weickert; Branka Brukner Dabovic; Daniel B Rifkin; Annelies Dheedene; Eveline Boudin; Oana Caluseriu; Marie-Claude Cholette; Ross Mcleod; Reynaldo Antequera; Marie-Paule Gellé; Jean-Louis Coeuriot; Louis-Frédéric Jacquelin; Isabelle Bailleul-Forestier; Marie-Cécile Manière; Wim Van Hul; Debora Bertola; Pascal Dollé; Alain Verloes; Geert Mortier; Hélène Dollfus; Agnès Bloch-Zupan
Journal:  Hum Mol Genet       Date:  2015-02-10       Impact factor: 6.150

Review 5.  Transient Receptor Potential Vanilloid in the Brain Gliovascular Unit: Prospective Targets in Therapy.

Authors:  Huilong Luo; Xavier Declèves; Salvatore Cisternino
Journal:  Pharmaceutics       Date:  2021-03-04       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.